
Xtant Medical Holdings XTNT
$ 0.47
3.11%
Annual report 2025
added 03-31-2026
Xtant Medical Holdings Interest Expense 2011-2026 | XTNT
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Xtant Medical Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.67 M | 4.16 M | 2.94 M | 1.69 M | 995 K | 5.98 M | 5.77 M | 10.1 M | 14.7 M | 12.3 M | 7.73 M | 5.66 M | 4.65 M | 1.86 M | 1.16 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.7 M | 995 K | 5.56 M |
Quarterly Interest Expense Xtant Medical Holdings
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -16 K | 1 M | - | -13 K | 992 K | 835 K | - | 760 K | 786 K | 575 K | - | 440 K | 397 K | 359 K | - | 329 K | 199 K | 1 K | - | 2.1 M | 2.05 M | 1.11 M | - | 1.18 M | 1.3 M | 2.02 M | - | 1.79 M | 2.82 M | 3.54 M | - | 3.81 M | 3.33 M | 3.4 M | - | 3.16 M | 2.98 M | 2.83 M | - | 2.11 M | 1.38 M | 1.44 M | - | 1.5 M | 1.44 M | 1.28 M | - | 1.2 M | 1.17 M | 1.06 M | - | 868 K | 266 K | 171 K | - | 541 K | 133 K | 372 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.81 M | -16 K | 1.34 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
7.68 M | $ 176.83 | 5.97 % | $ 13.2 B | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 11.66 | 5.71 % | $ 1.75 B | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
AxoGen
AXGN
|
167 K | $ 34.0 | 9.71 % | $ 1.57 B | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 12.18 | 2.01 % | $ 1.65 B | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 281.15 | 1.13 % | $ 7.93 B | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 38.25 | 4.31 % | $ 5.7 K | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 62.56 | 1.15 % | $ 92.6 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Electromed
ELMD
|
78 K | $ 24.4 | 2.61 % | $ 206 M | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 9.17 | 1.1 % | $ 260 M | ||
|
Globus Medical
GMED
|
3.41 M | $ 91.96 | 2.13 % | $ 12.4 B | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Butterfly Network
BFLY
|
-13 K | $ 4.14 | 2.22 % | $ 876 M | ||
|
Nevro Corp.
NVRO
|
-421 K | - | - | $ 217 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.37 | -0.88 % | $ 126 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
-70 K | $ 9.85 | 1.86 % | $ 353 M | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 36.59 | 5.94 % | $ 1.14 B | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.62 | 0.22 % | $ 122 M | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 81.71 | 1.08 % | $ 47.8 B | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 53.38 | -1.89 % | $ 1.57 B | ||
|
Varex Imaging Corporation
VREX
|
-4.4 M | $ 11.04 | 4.25 % | $ 457 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 1.88 | 2.73 % | $ 1.14 M | ||
|
Inogen
INGN
|
2.44 M | $ 6.67 | -1.91 % | $ 177 M | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 87.48 | 2.78 % | $ 3.04 B | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 16.01 | 1.59 % | $ 376 M |